Skip to main
  1. Stocks
  2. Viking Therapeutics
  3. Earnings
VKTX

Viking Therapeutics (VKTX) Earnings Dates & Reports

Viking Therapeutics (VKTX) Most Recent Earnings

Report Date
Period EndingQ3 2026
Est. EPS-$1.05
Actual EPS-$1.55
EarningsMiss

Viking Therapeutics (VKTX) Earnings

View the latest Viking Therapeutics (VKTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.

Start investing in Viking Therapeutics (VKTX)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Viking Therapeutics (VKTX) Earnings per Share (EPS) History

Signup for full access
Browse free

Viking Therapeutics (VKTX) Latest Earnings

The value each VKTX share was expected to gain vs. the value each share gained.

Viking Therapeutics (VKTX) reported its most recent earnings on for Q3 2026, posting earnings per share (EPS) of -$1.55. This exceeded analysts' expectations of -$1.05 by 47.62%, marking a Miss.

For comparison, Viking Therapeutics reported EPS of -$0.81 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$1.28.

Viking Therapeutics (VKTX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$1.28
Q3 2026
-$1.05-$1.55+47.62%
Q2 2026
-$1.21-$1.10-9.09%
Q1 2026
-$0.92-$1.37+48.91%
Q4 2025
-$0.90-$1.38+53.33%
View all

Viking Therapeutics (VKTX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Viking Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
———
———
———
———

Viking Therapeutics (VKTX) Earnings FAQs

Viking Therapeutics (VKTX) last reported earnings on Oct 28, 2026 for Q3 2026, posting an EPS of -$1.55, which Miss the estimate of -$1.05 by 47.62%.

For Q3 2026, Viking Therapeutics (VKTX) reported an EPS of -$1.55, missing analysts' estimate of -$1.05 by 47.62%.

For Q3 2026, Viking Therapeutics (VKTX) Miss expectations with an actual EPS of -$1.55 vs. an estimated EPS of -$1.05.

Following the last earnings report on Oct 28, 2026, Viking Therapeutics (VKTX)'s stock price moved — from — to —.

The next Viking Therapeutics (VKTX) earnings call is scheduled for Feb. 10, 2027, where executives will discuss financial results and outlook.

Viking Therapeutics (VKTX)


Viking Therapeutics (VKTX) Earnings

View the latest Viking Therapeutics (VKTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.

Start investing in Viking Therapeutics (VKTX)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover VKTX stock data and trends